发明名称 AZA AND AZA (N-OXY) ANALOGS OF GLYCINE/NMDA RECEPTOR ANTAGONISTS
摘要 Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's syndrome, treating or preventing adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia, and treating or preventing opiate tolerance are disclosed by administering to an animal in need of such treatment or prevention a substituted or unsubstituted pyridine and pyridine (N-oxide) analogs of 4-hydroxydihydroquinolones, tetrahydroquinoline-trione-oximes and quinoxalones of Formula (I), tautomers and pharmaceutically acceptable salts thereof, which have high binding to the glycine receptor or tautomers, pharmaceutically acceptable salts or N-oxides thereof; wherein A, D, E, G, R, R1, X, Y, Z are as defined in the description.
申请公布号 CA2211608(A1) 申请公布日期 1996.08.01
申请号 CA19952211608 申请日期 1995.12.21
申请人 STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON,EUGENE, OREGON;ACEA PHARMACEUTICALS, INC. 发明人 CAI, SUI XIONG;ZHOU, ZHANG-LIN;KEANA, JOHN F.W.;MARTIN, VLADIMIR V.;NAVRATIL, JAMES M.
分类号 C07D241/44;A61K31/4375;A61K31/444;A61K31/498;A61K31/519;A61P25/00;A61P25/04;A61P25/08;A61P25/14;A61P25/18;A61P25/22;A61P25/28;A61P25/36;A61P43/00;C07D241/52;C07D471/04;C07D475/00;C07D487/04;(IPC1-7):C07D471/04;C07D401/00;C07D403/00;C07D405/00;C07D409/00;C07D411/00;C07D413/00;C07D417/00;C07D473/00;C07D519/00;C07F7/10;A61K31/435;A61K31/495;A61K31/535;A61K31/54;A61K31/55;A61K31/695 主分类号 C07D241/44
代理机构 代理人
主权项
地址